From analysis to discovery

Driving the Future of Clinical Genetic Data Analysis

About Geneyx

The Company

Geneyx was founded in 2018 with the vision of ensuring every patient receives the value of genomics knowledge through a clinical genetics data management platform. Our solution analyzes and interprets NGS data using cutting-edge technology. With implementations in over 36 countries and more than 300,000 sample uploads, private/public laboratories, hospitals, and National Genome Projects have achieved up to 65% diagnostic yields. Whole exome (WE) analysis takes less than 30 minutes, while whole genome (WG) analysis is completed in 2.5 hours. 

The Technology

Geneyx Analysis is an innovative platform for analyzing and interpreting germline and somatic sequencing data. This comprehensive tool tailors to all aspects of in-house bioinformatic pipelines but alleviates the associated complexities of staying up to date with current genomic information. Our team strives to provide a resource that significantly improves diagnostic yields and turnaround times, and our mission is to provide a platform that achieves a world without undiagnosed diseases. Below are some of the key features that contribute to this mission.

Workflow Automation

Workflow automation is valuable in high-throughput environments but is also important for obtaining accurate results by removing manual errors. Geneyx Analysis promotes automation using APIs and batch upload features, which enable secure communication with LIMS and EHR systems and large sample workflows. Geneyx Analysis can also be implemented at any stage in the bioinformatic pipeline, Fastq or VCF, and provides detailed audit trails to monitor every step of the NGS pipeline.  

Whole Genome Sequencing Analysis

One distinct database valuable to whole genome sequencing analysis is the Geneyx Clinical Knowledgebase. This knowledgebase integrates machine learning to provide novel biomedical insights for gene-phenotype associations in coding and non-coding regions of the genome. Coupled with our innovative phenotype-driven interpretation algorithm, these features have led to important diagnoses in situations where exome sequencing has failed. As whole genome sequencing becomes the forefront in the clinical space, Geneyx Analysis will be a leading solution for interpretation.  

Advanced Annotations and Literature Sources

Staying relevant on annotation sources is fundamental to correct diagnoses. To alleviate the complexities with updating annotations, Geneyx Analysis implements automated annotation and database updates. In addition to well-known annotations, literature sources and best-practice guidelines are also updated regularly. This ensures clinical geneticists and bioinformaticians are utilizing leading-edge information to provide accurate and complete diagnoses to their patients.

Advanced Reporting Capabilities

Following analysis and interpretation of NGS data are reporting. Most labs outsource reporting to third-party platforms, but this can be expensive, tedious, and time-consuming.  Geneyx Analysis includes reporting capabilities within the software and allows reports to be fully customizable, including rendering in different languages.

Promoting A Resource for Discovery

Harnessing genetic data can be a valuable resource for identifying novel biomedical insights. Geneyx Analysis enables this through a warehouse environment to filter and search through all samples in an account to identify relevant cohorts and unique phenotype-gene associations.

In summary, Geneyx Analysis is a leading solution for NGS interpretation and evaluation. This platform aims to allow clinicians and geneticists to harness genetic data within their current infrastructure and promote improved diagnosis and treatment options. Geneyx Analysis addresses all bioinformatic needs and has been shown to improve diagnostic yields and turnaround time. This technology is advancing the field of next-generation sequencing and is advancing the field of precision medicine.


Meet Our Team

David Yizhar


Hagar Mor Shaked Ph.D.


Yaron Mazor


Sigalit Shachar


Raviv Itzhaky


Eli Sward Ph.D.

Associate Director Field Applications Support

Ceylan Atik

Vice president of Sales EMEA


Advisory Board

Matt Posard

Ex-Illumina VP International Sales. San Diego, California, United States

Prof. Yitzhak Pilpel

Head, Department of Molecular Genetics. Weizmann Institute of Science

Christian Tidona, PhD

Founder of BioMed X Institute. Heidelberg , Germany

Mostafa Kamal

Chief Executive Officer, Magellan Rx Management & EVP, Prime Therapeutics

Worldwide presence

36 Countries

Countries Map
Countries Map


Sales/Support Team

We’re always here for any questions, issues or brilliant ideas. Fill out the form below and a member of our team will be in touch.


Selected Videos

Geneyx Analysis Version 5.12 Release